- About Wuxi
- E-governance Hall
- Public Service
On September 11, AstraZeneca held it global board meeting in Wuxi. Li Xiaomin, Secretary of the CPC Wuxi Municipal Committee, and Huang Qin, Mayor of Wuxi, met with Leif Johansson, Non-Executive Chairman of the Board of AstraZeneca, and Pascal Soriot, Executive Director and Chief Executive Officer of AstraZeneca, and awarded Pascal Soriot the title of "Honorary Citizen of Wuxi". Wei Duo, Deputy Director of the Standing Committee of the Wuxi Municipal People's Congress, Wang Jinjian, Deputy Mayor of Wuxi, Secretary of the Party Working Committee of Wuxi National High-tech Zone, and Zhang Mingkang, Secretary General of the Wuxi Municipal People's Government, attended the meeting.
Li Xiaomin extended a warm welcome to the guests, thanked AstraZeneca for its long-term care and support to Wuxi, and briefly introduced the economic and social development of Wuxi. He said that the current world economic structure is undergoing profound adjustments, facing both greater challenges and rare opportunities. In this context, AstraZeneca has focused its development on China, placed it in Jiangsu, and placed it in Wuxi. We must have great potential and great achievements. We are full of confidence in this. This confidence is derived from the good cooperative relationship established by both sides. As the first foreign-invested enterprise invested and established in Wuxi National High-Tech Zone, AstraZeneca has made remarkable achievements in Wuxi for 26 years. Wuxi has also become AstraZeneca's production, sales, distribution and innovation headquarters in China. The profound friendship and harmonious relations between the two sides can provide a solid foundation for deepening cooperation. This confidence is also derived from the strategic direction and strategic pursuit shared by the two sides. In recent years, AstraZeneca has actively implemented the business development strategy of bio-pharmaceuticals, medical devices, new technologies and diversified product portfolios, while "biomedicine and medical devices" has been a key industrial cluster of Wuxi. The development goals and strategic orientation of the two sides can provide strong impetus for deepening cooperation. Nevertheless, the confidence is derived from Wuxi's superior development environment. Wuxi enjoys fertile industrial soil, a strong atmosphere of innovation, good geographical advantages and high-quality government services, which can provide a strong guarantee for deepening bilateral cooperation. The CPC Wuxi Municipal Committee and the Wuxi Municipal People's Government will, as always, create the best environment and provide the best service for AstraZeneca's investment and development in Wuxi, and work together to push bilateral strategic cooperation to a new level and achieve mutual benefit and win-win results.
Leif Johansson thanked the CPC Wuxi Municipal Committee and the Wuxi Municipal People's Government for their concern and support for AstraZeneca's development in Wuxi over the years. He said, "Wuxi has always been an important city for the development of AstraZeneca in China. During my visit to Wuxi, I saw that the staff of Wuxi base are highly educated, the production is efficient and standardized, and the equipment and facilities are first-class. I am deeply impressed that AstraZeneca Wuxi base has become an excellent operation center in the world, and AstraZeneca China's sustained rapid growth in recent years has strengthened our determination to stay in China." What is gratifying is that in March this year, AstraZeneca signed a strategic partnership agreement with Wuxi. In just a few months, Wuxi International Life Science Innovation Park officially opened. It is believed that the Innovation Park will establish an innovative ecosystem with the joint efforts of the government, enterprises and academia, and make positive contributions to the innovation development of Wuxi. AstraZeneca values its friendship with Wuxi over the years and the two sides will work together to benefit more patients. (Photo/Wuxi Daily)